Home » Archive by Category

Syndication

Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Receives Orphan Drug Designation In The United States And The European Union For The Treatment Of Malignant Pleural Mesothelioma

December 18, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 18, 2014 /PRNewswire/ –Polaris Group announced today that its lead product candidate ADI-PEG 20 (pegylated arginine deiminase) has received orphan drug designation for the treatment of malignant pleural mesothelioma (MPM) in the United States and in the European…

Halozyme Therapeutics, Inc. Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer

December 18, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 19, 2014 /PRNewswire/ –Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the European Commission, acting on the recommendation from the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA), has designated PEGylated recombinant human hyaluronidase (PEGPH…

ResMed Inc. To Announce Second Quarter 2015 Results

December 18, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 18, 2014 /PRNewswire/ –RESMED INC. (NYSE: RMD) today announced that it will report its second quarter of fiscal year 2015 results on Thursday, January 22, 2015, after the New York Stock Exchange market close. A press release with ResMed’s results will be issued after…

Cytori Therapeutics, Inc. And Biomedical Advanced Research and Development Authority (BARDA) Amend Contract Option To Accelerate The Advancement Of A Thermal Burn Injury Countermeasure

December 18, 2014 – 5:00 pm | Edit Post

Increased Option Value of $14.1 Million plus $8.3 Million for FDA Approved Clinical Trial SAN DIEGO–(BUSINESS WIRE)–Cytori Therapeutics (NASDAQ: CYTX…

Ligand Pharmaceuticals Inc. Partner Pfizer Receives European Marketing Authorization For DUAVIVE?? (Conjugated Estrogens/Bazedoxifene) For Treatment Of Estrogen Deficiency Symptoms In Postmenopausal Women With A Uterus

December 18, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Pfizer has received EU marketing authorization for DUAVIVE (conjugated estrogens/bazedoxifene (BZA/CE)) from the European Commission. In the EU, DUAVIVE is indicated for the treatment of …

Sorrento Therapeutics, Inc. And Announce Exclusive Global Collaboration

December 18, 2014 – 5:00 pm | Edit Post

SAN DIEGO and CARDIFF-BY-THE-SEA, Calif., Dec. 19, 2014 /PRNewswire/ –Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, and Conkwest, Inc., a privately-held immuno-oncology company developing proprietary…

Sienna Labs Obtains Sixth Patent Relating To Use Of Plasmonic Nanoparticles In Treatment Of Sebaceous Glands And Hair

December 18, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 19, 2014 /PRNewswire/ — Sienna Labs announced today that the U.S. Patent and Trademark Office issued U.S. Patent No.8,906,418 covering, among other aspects, methods of using the company’s targeted plasmonic therapy (TPT) platform for localizing thermal damageto sebaceous glands and hair, a key…

Sorrento Therapeutics, Inc. And Announce Exclusive Global Collaboration

December 18, 2014 – 5:00 pm | Edit Post

SAN DIEGO and CARDIFF-BY-THE-SEA, Calif., Dec. 19, 2014 /PRNewswire/ –Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, and Conkwest, Inc., a privately-held immuno-oncology company developing proprietary…

Orexigen Therapeutics, Inc.’s Mysimba (Naltrexone Hcl / Bupropion Hcl Prolonged Release) Receives Positive CHMP Opinion Recommending Approval For Weight Management In The European Union

December 18, 2014 – 5:00 pm | Edit Post

LA JOLLA, Calif., Dec. 19, 2014 /PRNewswire/ –Orexigen Therapeutics (NASDAQ: OREX) announced today that the Committee for Medicinal Products For Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a centralized marketing authorization for Mysimba…

Field Engineer – Life Sciences – GE Healthcare – San Diego, CA

December 18, 2014 – 4:48 pm | Edit Post

Job Number 2026703 The GE Healthcare Life Sciences Field Service Engineer will be responsible for meeting the daily service repair needs of the customer’s
From GE Careers – 18 Dec 2014 23:48:00 GMT
– View all San Diego jobs